Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Lonza Group Ltd (LONN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
738.60+22.20 (+3.10%)
At close: 5:31PM CET
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close716.40
Open704.40
Bid0.00 x 0
Ask0.00 x 0
Day's Range701.80 - 754.60
52 Week Range516.20 - 785.40
Volume247,470
Avg. Volume141,111
Market Cap54.865B
Beta (5Y Monthly)0.42
PE Ratio (TTM)77.56
EPS (TTM)9.52
Earnings DateJan 26, 2022
Forward Dividend & Yield3.00 (0.41%)
Ex-Dividend DateMay 10, 2021
1y Target Est762.54
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LONN.SW

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Motley Fool

      Should You Have Lonza Stock on Your Watchlist?

      In this Motley Fool Live video recorded on Nov. 3, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether investors should have Lonza on their watchlists. Keith Speights: Brian, one final topic before we get to questions.

    • Reuters

      UPDATE 3-Moderna says COVID-19 vaccine supply outside United States to slow down

      Moderna said on Tuesday its COVID-19 vaccine manufacturing partners outside the United States are facing delays due to laboratory testing operations that have occurred in the past few days, slowing the supply of the shot to these markets. The vaccine maker's comments come after South Korean health officials said earlier in the day that Moderna has delayed its late-July vaccine shipment schedule for the country to August due to supply problems. "We are currently not reserving safety stock to allow vaccines to be delivered faster, which means that we do not have stock in storage to smooth these types of shortfalls or delays," a Moderna spokesperson said.

    Advertisement
    Advertisement